FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury

Kidney International

Volumn 65, Issue 3, 2004, Pages 1076-1083

  Dragun, Duska ^a   Böhler, Torsten ^b   Nieminen Kelhä, Melina ^b   Waiser, Johannes ^b   Schneider, Wolfgang ^b   Haller, Hermann ^b   Luft, Friedrich C ^b   Budde, Klemens ^b   Neumayer, Hans Hellmut ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Endothelium; Inflammation; Lymphocyte homing; Monocytes; Neutrophils

Indexed keywords

CD31 ANTIGEN; CREATININE; FINGOLIMOD; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNIVERSITY OF WISCONSIN SOLUTION; VASCULAR CELL ADHESION MOLECULE 1;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; HISTOCHEMISTRY; HISTOLOGY; INFLAMMATORY CELL; ISOGRAFT; KIDNEY GRAFT; LYMPH NODE; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; LYMPHOCYTOPENIA; MACROPHAGE; MALE; NEUTROPHIL; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SCORING SYSTEM; SINGLE DRUG DOSE; T LYMPHOCYTE; TISSUE SECTION; TUBULAR DYSFUNCTION;

EID: 1342322649     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00478.x     Document Type: Article

References (31)

1. OJO A, WOLFE RA, HELD PJ, et al: Delayed graft function: Risk factors and implications for renal survival. Transplant 63:968-974, 1997
2. DANOVITCH G: Immunosuppressive medications for renal transplantation: A multiple choice question. Kidney Int 59:88-402, 2001
3. BRINKMANN V, PINSCHEWER DD, FENG L, CHEN S: FTY720: Altered lymphocyte traffic results in allograft protection. Transplant 72:764-769, 2001
4. BRINKMANN V, LYNCH KR: FTY720: Targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr Opin Immunol 14:569-575, 2002
5. ZWACKA R, ZHANG Y, HALLDORSON J, et al: CD4+ T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 100:279-289, 1997
6. BURNE M, DANIELS F, EL GHANDOUR A, et al: Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 108:1283-1290, 2001
7. DRAGUN D, HOFF U, PARK J-K, et al: Prolonged cold preservation augments vascular injury independent of renal Transplant immunogenecity and function. Kidney Int 60:1173-1181, 2001
8. DRAGUN, D, HOFF U, PARK J-K, et al: Ischemia-reperfusion injury in renal transplantation is independent of immunological background. Kidney Int 58:2166-2177, 2000
9. BURNE-TANEY MJ, RABB H: The role of adhesion molecules and T cells in ischemic renal injury. Curr Opin Nephrol Hypert 12:85-90, 2003
10. BUDDE K, SCHMOUDER RL, BRUNKHORST R, et al: First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients. J Am Soc Nephrol 13:1073-1083, 2002
11. TILNEY N, GUTTMAN RD: Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplant 64:945-947, 1997
12. YSEBAERT DK, DE GREEF K, VERCAUTEREN SR, et al: Identification and kinetics of leukocytes after severe ischemia/reperfusion injury. Nephrol Dial Transplant 15:1562-1574, 2000
13. GABER L, GABER AO, HATHAWAY DK, et al: Routine early biposy of allografts with delayed function: correlation of histopathology and transplant outcome. Clin Transplant 10:629-634, 1996
14. KOO D, WELSH KI, ROAKE JA, et al: Ischemia/reperfusion injury in human kidney transplantation: An immunohistochemical analysis of changes after reperfusion. Am J Pathol 153:557-566, 1998
15. DRAGUN D, TULLIUS SG, PARK J-K, et al: ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int 54:590-602, 1998
16. DE GREEF KE, YSEBAERT DK, DAUWE S, et al: Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int 60:1415-1427, 2001
17. BURNE MJ, ELGHANDOUR A, HAQ M, et al: IL-1 and TNF independent pathways mediate ICAM-1/VCAM-1 up-regulation in ischemia-reperfusion injury. J Leukoc Biol 70:192-198, 2001
18. GERRITSEN M, BLOOR CM: Endothelial cell gene expression in response to injury. FASEB J 7:523-532, 1993
19. BRINKMANN V, DAVIS M, HEISE CE, et al: The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277:21453-21457, 2002
20. LEE MJ, THANGADA S, CLAFFEY KP, et al: Vascular endothelial cell adherens juction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99:301-312, 1999
21. DOHERTY TM: T-cell regulation of macrophage function. Curr Opin Immunol 7:400-404, 1995
22. BUDDE K, SCHMOUDER RL, NASHAN B, et al: Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients. Am J Transplant 3:846-854, 2003
23. REMUZZI G, PERICO N: Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int 48:S70-S74, 1995
24. VALENTIN J, BRUIJN JA, PAUL LC: Donor treatment with mycophenolate mofetil: Protection against ischemia-reperfusion injury in the rat. Transplant 69:344-350, 2000
25. VENTURA CG, MAHCADO COIMBRA T, DE CAMPOS SB, et al: Mycophenolate mofetil attenuates renal ischemia/reperfusion injury. J Am Soc Nephrol 13:2524-2533, 2002
26. SUN DF, FUJIGAKI Y, FUJIMOTO T, et al: Myophenolate mofetil inhibits regenerative repair in uranyl acetate-induced acute renal failure by reduced interstitial response. Am J Pathol 161:217-227, 2002
27. YOKOTA N, DANIELS F, CROSSON J, RABB H: Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplant 74:759-763, 2002
28. ABRAMOWICZ D, NORMAN DJ, VEREERSTRAETEN P, et al: OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: Association with improvement in long-term survival. Kidney Int 49:768-772, 1996
29. KREIS H: Adverse events associated with OKT3 immunosuppression in the prevention or treatment of allograft rejection. Clin Transplant 7:431-446, 1993
30. PINSCHEWER DD, OCHESENBEIN AF, ODERMATT B, et al: FTY immunosuppression impairs effector T-cell peripheral homing without affecting induction, expansion, and memory. J Immunol 164:5761-5770, 2000
31. YANAGAWA Y, SUGAHARA K, KATAOKA H, et al: FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol 160:5493-5499, 1998